RFXANK Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with RFXANK Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with RFXANK Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with RFXANK Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RFXANK Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000082701 - glycogen synthase kinase 3 beta

Gene

ENSG00000131100 - ATPase H+ transporting V1 subunit E1

Gene

ENSG00000144048 - dual specificity phosphatase 11

Gene

ENSG00000107960 - STN1 subunit of CST complex

Gene

ENSG00000115520 - coenzyme Q10B

Gene

ENSG00000128524 - ATPase H+ transporting V1 subunit F

Gene

ENSG00000109270 - late endosomal/lysosomal adaptor, MAPK and MTOR activator 3

Gene

ENSG00000148795 - cytochrome P450 family 17 subfamily A member 1

  • Gene

    ENSG00000082701 - glycogen synthase kinase 3 beta


  • Gene

    ENSG00000131100 - ATPase H+ transporting V1 subunit E1


  • Gene

    ENSG00000144048 - dual specificity phosphatase 11


  • Gene

    ENSG00000107960 - STN1 subunit of CST complex


  • Gene

    ENSG00000115520 - coenzyme Q10B


  • Gene

    ENSG00000128524 - ATPase H+ transporting V1 subunit F


  • Gene

    ENSG00000109270 - late endosomal/lysosomal adaptor, MAPK and MTOR activator 3


  • Gene

    ENSG00000148795 - cytochrome P450 family 17 subfamily A member 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.